IMCAS 2026 was a real success for Skin Tech Pharma Group.
Hundreds of physicians from more than 70 countries showed strong interest in our Skin Builder Lab, where our R&D team demonstrated in depth the properties and clinical performance of Skin Builder RRS® HA Long Lasting.
This interest was further reflected in the full attendance at the Symposium and the Live Demo organized by Skin Tech Pharma Group on the first day of the congress, both with a completely packed room.
These results in IMCAS confirm the Skin Builder as this new injectable category, exclusive to Skin Tech Pharma Group, effectively fills an existing gap between boosters and fillers, addressing a clear unmet need for both physicians and patients.
In addition, significant attention was also directed toward our chemical peelings and, especially, our injectable solutions for body and hair indications. Showing that aesthetics goes forwarder than just face.
Thanks all the professionals who visited our stand during the congress, engaging with our team and portfolio.
We look forward to meeting you again at future scientific events.
